Correction to: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8)

Xihui Liu; Suryavathi Viswanadhapalli; Shourya Kumar; Tae Kyung Lee; Andrew Moore; Shihong Ma; Liping Chen; Michael Hsieh; Mengxing Li; Gangadhara R. Sareddy; Karla Parra; Eliot B. Blatt; Tanner C. Reese; Yuting Zhao; Annabel Chang; Hui Yan; Zhenming Xu; Uday P. Pratap; Zexuan Liu; Carlos M. Roggero; Zhenqiu Tan; Susan T. Weintraub; Yan Peng; Rajeshwar R. Tekmal; Carlos L. Arteaga; Jennifer Lippincott-Schwartz; Ratna K. Vadlamudi; Jung Mo Ahn; Ganesh V. Raj

doi:10.1038/s43018-024-00783-4

Correction to: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8)

Xihui Liu, Suryavathi Viswanadhapalli, Shourya Kumar, Tae Kyung Lee, Andrew Moore, Shihong Ma, Liping Chen, Michael Hsieh, Mengxing Li, Gangadhara R. Sareddy, Karla Parra, Eliot B. Blatt, Tanner C. Reese, Yuting Zhao, Annabel Chang, Hui Yan, Zhenming Xu, Uday P. Pratap, Zexuan Liu, Carlos M. RoggeroZhenqiu Tan, Susan T. Weintraub, Yan Peng, Rajeshwar R. Tekmal, Carlos L. Arteaga, Jennifer Lippincott-Schwartz, Ratna K. Vadlamudi, Jung Mo Ahn, Ganesh V. Raj

Department of Biochemistry & Structural Biology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Nature Cancerhttps://doi.org/10.1038/s43018-022-00389-8, published online 2 June 2022 In the version of this article initially published, in the legend to Extended Data Fig. 2a, the dose of ERX-41 was reported as 10 mg/kg/day for both BALB/c and nude mice, but the BALB/c mice were in fact administered 20 mg/kg/day. The correct figure legend for Extended Data Fig. 2a is “Nude mice with MDA-MB-231 xenograft tumors were treated with either a vehicle or ERX-41 (10 mg/kg/day) for a duration of 52 days. Similarly, BALB/c mice with D2A1 xenograft tumors received a treatment of 20 mg/kg/day for 23 days. Following these treatments, histologic architecture in various organs of both the nude mice and BALB/c mice was assessed using H&E staining (a).” This has been corrected in the HTML and PDF versions of the article.

Original language	English (US)
Pages (from-to)	953
Number of pages	1
Journal	Nature Cancer
Volume	5
Issue number	6
DOIs	https://doi.org/10.1038/s43018-024-00783-4
State	Published - Jun 2024

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1038/s43018-024-00783-4

Fingerprint

Dive into the research topics of 'Correction to: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8)'. Together they form a unique fingerprint.

Cite this

Liu, X., Viswanadhapalli, S., Kumar, S., Lee, T. K., Moore, A., Ma, S., Chen, L., Hsieh, M., Li, M., Sareddy, G. R., Parra, K., Blatt, E. B., Reese, T. C., Zhao, Y., Chang, A., Yan, H., Xu, Z., Pratap, U. P., Liu, Z., ... Raj, G. V. (2024). Correction to: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8). Nature Cancer, 5(6), 953. https://doi.org/10.1038/s43018-024-00783-4

Correction to: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8). / Liu, Xihui; Viswanadhapalli, Suryavathi; Kumar, Shourya et al.
In: Nature Cancer, Vol. 5, No. 6, 06.2024, p. 953.

Research output: Contribution to journal › Comment/debate › peer-review

Liu, X, Viswanadhapalli, S, Kumar, S, Lee, TK, Moore, A, Ma, S, Chen, L, Hsieh, M, Li, M, Sareddy, GR, Parra, K, Blatt, EB, Reese, TC, Zhao, Y, Chang, A, Yan, H , Xu, Z , Pratap, UP, Liu, Z, Roggero, CM, Tan, Z, Weintraub, ST, Peng, Y, Tekmal, RR, Arteaga, CL, Lippincott-Schwartz, J, Vadlamudi, RK, Ahn, JM & Raj, GV 2024, 'Correction to: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8)', Nature Cancer, vol. 5, no. 6, pp. 953. https://doi.org/10.1038/s43018-024-00783-4

@article{792e052fa9354c2c88e242024a2dfd4d,

title = "Correction to: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8)",

abstract = "Correction to: Nature Cancerhttps://doi.org/10.1038/s43018-022-00389-8, published online 2 June 2022 In the version of this article initially published, in the legend to Extended Data Fig. 2a, the dose of ERX-41 was reported as 10 mg/kg/day for both BALB/c and nude mice, but the BALB/c mice were in fact administered 20 mg/kg/day. The correct figure legend for Extended Data Fig. 2a is “Nude mice with MDA-MB-231 xenograft tumors were treated with either a vehicle or ERX-41 (10 mg/kg/day) for a duration of 52 days. Similarly, BALB/c mice with D2A1 xenograft tumors received a treatment of 20 mg/kg/day for 23 days. Following these treatments, histologic architecture in various organs of both the nude mice and BALB/c mice was assessed using H&E staining (a).” This has been corrected in the HTML and PDF versions of the article.",

author = "Xihui Liu and Suryavathi Viswanadhapalli and Shourya Kumar and Lee, {Tae Kyung} and Andrew Moore and Shihong Ma and Liping Chen and Michael Hsieh and Mengxing Li and Sareddy, {Gangadhara R.} and Karla Parra and Blatt, {Eliot B.} and Reese, {Tanner C.} and Yuting Zhao and Annabel Chang and Hui Yan and Zhenming Xu and Pratap, {Uday P.} and Zexuan Liu and Roggero, {Carlos M.} and Zhenqiu Tan and Weintraub, {Susan T.} and Yan Peng and Tekmal, {Rajeshwar R.} and Arteaga, {Carlos L.} and Jennifer Lippincott-Schwartz and Vadlamudi, {Ratna K.} and Ahn, {Jung Mo} and Raj, {Ganesh V.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = jun,

doi = "10.1038/s43018-024-00783-4",

language = "English (US)",

volume = "5",

pages = "953",

journal = "Nature Cancer",

issn = "2662-1347",

publisher = "Nature Research",

number = "6",

}

TY - JOUR

T1 - Correction to

T2 - Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8)

AU - Liu, Xihui

AU - Viswanadhapalli, Suryavathi

AU - Kumar, Shourya

AU - Lee, Tae Kyung

AU - Moore, Andrew

AU - Ma, Shihong

AU - Chen, Liping

AU - Hsieh, Michael

AU - Li, Mengxing

AU - Sareddy, Gangadhara R.

AU - Parra, Karla

AU - Blatt, Eliot B.

AU - Reese, Tanner C.

AU - Zhao, Yuting

AU - Chang, Annabel

AU - Yan, Hui

AU - Xu, Zhenming

AU - Pratap, Uday P.

AU - Liu, Zexuan

AU - Roggero, Carlos M.

AU - Tan, Zhenqiu

AU - Weintraub, Susan T.

AU - Peng, Yan

AU - Tekmal, Rajeshwar R.

AU - Arteaga, Carlos L.

AU - Lippincott-Schwartz, Jennifer

AU - Vadlamudi, Ratna K.

AU - Ahn, Jung Mo

AU - Raj, Ganesh V.

PY - 2024/6

Y1 - 2024/6

N2 - Correction to: Nature Cancerhttps://doi.org/10.1038/s43018-022-00389-8, published online 2 June 2022 In the version of this article initially published, in the legend to Extended Data Fig. 2a, the dose of ERX-41 was reported as 10 mg/kg/day for both BALB/c and nude mice, but the BALB/c mice were in fact administered 20 mg/kg/day. The correct figure legend for Extended Data Fig. 2a is “Nude mice with MDA-MB-231 xenograft tumors were treated with either a vehicle or ERX-41 (10 mg/kg/day) for a duration of 52 days. Similarly, BALB/c mice with D2A1 xenograft tumors received a treatment of 20 mg/kg/day for 23 days. Following these treatments, histologic architecture in various organs of both the nude mice and BALB/c mice was assessed using H&E staining (a).” This has been corrected in the HTML and PDF versions of the article.

AB - Correction to: Nature Cancerhttps://doi.org/10.1038/s43018-022-00389-8, published online 2 June 2022 In the version of this article initially published, in the legend to Extended Data Fig. 2a, the dose of ERX-41 was reported as 10 mg/kg/day for both BALB/c and nude mice, but the BALB/c mice were in fact administered 20 mg/kg/day. The correct figure legend for Extended Data Fig. 2a is “Nude mice with MDA-MB-231 xenograft tumors were treated with either a vehicle or ERX-41 (10 mg/kg/day) for a duration of 52 days. Similarly, BALB/c mice with D2A1 xenograft tumors received a treatment of 20 mg/kg/day for 23 days. Following these treatments, histologic architecture in various organs of both the nude mice and BALB/c mice was assessed using H&E staining (a).” This has been corrected in the HTML and PDF versions of the article.

UR - http://www.scopus.com/inward/record.url?scp=85193546706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85193546706&partnerID=8YFLogxK

U2 - 10.1038/s43018-024-00783-4

DO - 10.1038/s43018-024-00783-4

M3 - Comment/debate

C2 - 38769429

AN - SCOPUS:85193546706

SN - 2662-1347

VL - 5

SP - 953

JO - Nature Cancer

JF - Nature Cancer

IS - 6

ER -

Correction to: Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress (Nature Cancer, (2022), 3, 7, (866-884), 10.1038/s43018-022-00389-8)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this